Sachem Capital Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between December 17, 2020, and December 22, 2020. Sachem Capital Corp. (the "Company") is a business development company incorporated in New York. The filing primarily details the execution and closing of a public offering of senior notes.
Key Financial Metrics and Transaction Details
The Company consummated the sale of $25,000,000 aggregate principal amount of 7.75% Notes due 2025. Key financial terms of the transaction include:
- Gross Proceeds: $24,750,000 (offered at a 1% discount).
- Net Proceeds: $23,945,625 (after deducting underwriting discounts and commissions).
- Underwriting Discount: 3.25% ($0.804375 per Note).
- Over-Allotment Option: Underwriters hold a 30-day option to purchase up to an additional $3,750,000 of Notes.
- Debt Structure: These Notes rank equally with and form a single series with $28,363,750 of existing 7.75% Notes due 2025 issued in September and October 2020.
The filing does not provide updated revenue, profit, cash flow, or margin data for the reporting period, as this is a transaction-specific filing rather than a periodic financial report.
Material Changes
The primary material change is the increase in the Company's outstanding debt obligations. The issuance of the new Notes increases the total principal amount of the 2025 Notes series from $28,363,750 to $53,363,750 (excluding potential over-allotment). The Company received immediate liquidity in the form of net proceeds of approximately $23.9 million.
Outlook, Risks, and Management Commentary
The Company utilized a shelf registration statement (Form S-3) declared effective on February 5, 2020, to facilitate this offering. The Notes were listed on the NYSE American under the symbol "SCCC." The filing references customary representations, warranties, and indemnification obligations within the Underwriting Agreement but does not provide specific forward-looking guidance or management commentary regarding future operational performance beyond the completion of this capital raise.
Investor Verification Checklist
- Verify the total outstanding principal of the 7.75% Notes due 2025, including any exercise of the $3,750,000 over-allotment option.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) and the Third Supplemental Indenture (Exhibit 4.1) for specific covenants and redemption terms.
- Confirm the use of the $23,945,625 in net proceeds in subsequent periodic reports (10-Q or 10-K).
- Check for any subsequent filings regarding the exercise or expiration of the underwriters' over-allotment option by January 17, 2021.